ULYM17025 / ILyAD / Jonathan FriedbergResearch Question:
Can modification of vitamin D levels in the blood, through supplementation, improve
outcomes in patients with indolent lymphoma treated with rituximab?
Basic Study Information
Purpose:Location: Cancer Center
Despite strong evidence suggesting that vitamin D deficiency is associated with undesirable
outcomes in patients with numerous cancers, there has never been a thorough study
of vitamin D treatment in subjects undergoing treatment for cancer. The purpose of
this study is to evaluate whether modification of vitamin D levels in the blood, through
supplementation, can improve outcomes.
Study Web URL: https://clinicaltrials.gov/ct2/show/NCT03078855?term=ilyad&rank=1
Study Reference #: ULYM17025
Lead Researcher (Principal Investigator)
Jonathan Friedberg, MD
Study Contact InformationStudy Coordinator: Amber Johnson
Additional Study Details
Learn More About These Conditions
More information about Lymphoma
Trial Not Found
The study you are looking for is not active at this time.
Return to Search